vs
英美资源集团（AMSC）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是英美资源集团的1.7倍（$127.1M vs $74.5M），英美资源集团同比增速更快（21.4% vs 17.1%），英美资源集团自由现金流更多（$2.4M vs $-26.7M），过去两年英美资源集团的营收复合增速更高（33.2% vs 20.8%）
英美资源集团是一家总部位于英国伦敦的跨国矿业企业，是全球最大的铂金生产商，产量约占全球总产出的40%，同时也是钻石、铜、镍、铁矿石、多卤石、炼焦煤的主要供应商，业务布局覆盖非洲、亚洲、大洋洲、欧洲、南北美洲多个地区。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
AMSC vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.7倍
$74.5M
营收增速更快
AMSC
高出4.3%
17.1%
自由现金流更多
AMSC
多$29.1M
$-26.7M
两年增速更快
AMSC
近两年复合增速
20.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.5M | $127.1M |
| 净利润 | $117.8M | — |
| 毛利率 | 30.7% | 51.0% |
| 营业利润率 | 4.5% | -54.6% |
| 净利率 | 158.1% | — |
| 营收同比 | 21.4% | 17.1% |
| 净利润同比 | 4679.1% | — |
| 每股收益（稀释后） | $2.62 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSCZLAB
| Q4 25 | $74.5M | $127.1M | ||
| Q3 25 | $65.9M | $115.4M | ||
| Q2 25 | $72.4M | $109.1M | ||
| Q1 25 | $66.7M | $105.7M | ||
| Q4 24 | $61.4M | $108.5M | ||
| Q3 24 | $54.5M | $101.8M | ||
| Q2 24 | $40.3M | $100.1M | ||
| Q1 24 | $42.0M | $87.1M |
净利润AMSCZLAB
| Q4 25 | $117.8M | — | ||
| Q3 25 | $4.8M | $-36.0M | ||
| Q2 25 | $6.7M | $-40.7M | ||
| Q1 25 | $1.2M | $-48.4M | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $4.9M | $-41.7M | ||
| Q2 24 | $-2.5M | $-80.3M | ||
| Q1 24 | $-1.6M | $-53.5M |
毛利率AMSCZLAB
| Q4 25 | 30.7% | 51.0% | ||
| Q3 25 | 31.0% | 59.5% | ||
| Q2 25 | 33.8% | 60.6% | ||
| Q1 25 | 26.5% | 63.6% | ||
| Q4 24 | 26.6% | 61.5% | ||
| Q3 24 | 28.7% | 64.1% | ||
| Q2 24 | 30.3% | 64.9% | ||
| Q1 24 | 24.8% | 61.4% |
营业利润率AMSCZLAB
| Q4 25 | 4.5% | -54.6% | ||
| Q3 25 | 4.5% | -42.3% | ||
| Q2 25 | 7.8% | -50.3% | ||
| Q1 25 | 2.5% | -53.3% | ||
| Q4 24 | 2.1% | -62.6% | ||
| Q3 24 | -1.4% | -66.6% | ||
| Q2 24 | -8.2% | -76.0% | ||
| Q1 24 | -5.3% | -80.7% |
净利率AMSCZLAB
| Q4 25 | 158.1% | — | ||
| Q3 25 | 7.2% | -31.2% | ||
| Q2 25 | 9.3% | -37.3% | ||
| Q1 25 | 1.8% | -45.8% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.0% | -40.9% | ||
| Q2 24 | -6.3% | -80.2% | ||
| Q1 24 | -3.8% | -61.4% |
每股收益（稀释后）AMSCZLAB
| Q4 25 | $2.62 | $-0.05 | ||
| Q3 25 | $0.11 | $-0.03 | ||
| Q2 25 | $0.17 | $-0.04 | ||
| Q1 25 | $0.04 | $-0.04 | ||
| Q4 24 | $0.06 | $-0.09 | ||
| Q3 24 | $0.13 | $-0.04 | ||
| Q2 24 | $-0.07 | $-0.08 | ||
| Q1 24 | $-0.03 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.1M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $536.8M | $715.5M |
| 总资产 | $719.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMSCZLAB
| Q4 25 | $141.1M | $689.6M | ||
| Q3 25 | $212.9M | $717.2M | ||
| Q2 25 | $207.9M | $732.2M | ||
| Q1 25 | $79.5M | $757.3M | ||
| Q4 24 | $75.2M | $779.7M | ||
| Q3 24 | $72.1M | $616.1M | ||
| Q2 24 | $93.5M | $630.0M | ||
| Q1 24 | $90.5M | $650.8M |
股东权益AMSCZLAB
| Q4 25 | $536.8M | $715.5M | ||
| Q3 25 | $342.2M | $759.9M | ||
| Q2 25 | $333.1M | $791.7M | ||
| Q1 25 | $197.1M | $810.8M | ||
| Q4 24 | $192.7M | $840.9M | ||
| Q3 24 | $187.0M | $667.7M | ||
| Q2 24 | $143.3M | $704.2M | ||
| Q1 24 | $144.6M | $762.2M |
总资产AMSCZLAB
| Q4 25 | $719.5M | $1.2B | ||
| Q3 25 | $445.6M | $1.2B | ||
| Q2 25 | $452.8M | $1.2B | ||
| Q1 25 | $310.5M | $1.2B | ||
| Q4 24 | $310.3M | $1.2B | ||
| Q3 24 | $298.4M | $985.3M | ||
| Q2 24 | $240.1M | $987.4M | ||
| Q1 24 | $232.8M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $-26.7M |
| 自由现金流率自由现金流/营收 | 3.2% | -21.0% |
| 资本支出强度资本支出/营收 | 1.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.03× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流AMSCZLAB
| Q4 25 | $3.2M | $-26.0M | ||
| Q3 25 | $6.5M | $-32.0M | ||
| Q2 25 | $4.1M | $-31.0M | ||
| Q1 25 | $6.3M | $-61.7M | ||
| Q4 24 | $5.9M | $-55.8M | ||
| Q3 24 | $12.7M | $-26.8M | ||
| Q2 24 | $3.4M | $-42.2M | ||
| Q1 24 | $2.2M | $-90.1M |
自由现金流AMSCZLAB
| Q4 25 | $2.4M | $-26.7M | ||
| Q3 25 | $5.1M | $-35.0M | ||
| Q2 25 | $3.3M | $-33.9M | ||
| Q1 25 | $5.3M | $-63.2M | ||
| Q4 24 | $5.3M | $-58.4M | ||
| Q3 24 | $12.1M | $-28.2M | ||
| Q2 24 | $3.1M | $-42.9M | ||
| Q1 24 | $1.9M | $-91.1M |
自由现金流率AMSCZLAB
| Q4 25 | 3.2% | -21.0% | ||
| Q3 25 | 7.7% | -30.4% | ||
| Q2 25 | 4.6% | -31.1% | ||
| Q1 25 | 7.9% | -59.9% | ||
| Q4 24 | 8.7% | -53.8% | ||
| Q3 24 | 22.3% | -27.7% | ||
| Q2 24 | 7.8% | -42.9% | ||
| Q1 24 | 4.6% | -104.5% |
资本支出强度AMSCZLAB
| Q4 25 | 1.2% | 0.5% | ||
| Q3 25 | 2.1% | 2.6% | ||
| Q2 25 | 1.1% | 2.6% | ||
| Q1 25 | 1.6% | 1.5% | ||
| Q4 24 | 0.9% | 2.4% | ||
| Q3 24 | 1.1% | 1.3% | ||
| Q2 24 | 0.7% | 0.7% | ||
| Q1 24 | 0.7% | 1.1% |
现金转化率AMSCZLAB
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
